XTLB (XTL Biopharmaceuticals Ltd) Sof foyda

XTLB (XTL Biopharmaceuticals Ltd.) - kompaniyaning tovar belgisi

Mablag'lar yetishmovchiligi XTL Biopharmaceuticals (XTLB) kompaniyasini o'z pozitsiyasini mustahkamlash uchun biofarmatsevtika aktivlarini ehtiyotkorlik bilan sotib olishga majbur qilmoqda. Atrof-muhit barqarorligi ESG standartlarining joriy etilishi va zaharli chiqindilarning kamaytirilishi bilan tasdiqlanadi. Kompaniyaning sof foydasi moliyaviy barqarorlikni namoyish etadi, bunda joriy parametr 0.00 ga tengdir. Biznes barqarorligi surunkali patologiyalarga qarshi kurashish uchun AQSh va Isroilda immunoterapiya ishlanmalarining litsenziyalanishiga tayanadi.

XTLB (XTL Biopharmaceuticals) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

XTL Biopharmaceuticals Ltd. (XTLB) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari XTL Bio|XTLB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi XTL Bio|XTLB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati XTL Biopharmaceuticals|XTLB - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com|XTLB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati XTL Biopharmaceuticals Ltd|XTLB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar XTL Bio|XTLB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi XTL Biopharmaceuticals|Shoshilinch likvidlik xtlbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
XTLB - Sof daromad
Kompaniyaning jamlanma tahlili:XTL Biopharmaceuticals
XTL Biopharmaceuticals, Ltd. asosiy tovari

Autoimmun kasalliklar terapiyasi uchun uzoq muddatli patentlar bemorlar oqimining barqarorligini ta'minlab, XTL Biopharmaceuticals kompaniyasiga tizimli daromad olish uchun asos yaratadi. Kompaniyaning foyda hajmi dinamikasi valyuta risklari va xomashyo tebranishlari ta'siridagi kunlik sof foyda o'zgarishlarini aks ettiradi, bu esa investorlarga ushbu grafik tahlili orqali moliyaviy pasayishlar amplitudasini va umumiy kapital barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|PHAR (Pharming Corp) - Kompaniya foydasi|NKTR (Nektar Therapeutics) - Sof daromad|UPB: Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof daromad GOSS (Gossamer Corp)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Astria Corp (ATXS)|Kompaniyaning sof foydasi enGene Holdings Inc.|rapt.com - Soliqdan keyingi foyda|Sof foyda JBIO|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Sof foyda KYTX (Kyverna)|Sof foyda Tiziana Life Sciences, Ltd. TLSA|CABA - Kompaniyaning sof foydasi|Yakuniy foyda VTYX (ventyxbio.com)|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Sof daromad Avalo Therapeutics, Inc.|ELDN (Eledon) - Sof foyda|Sof foyda Agenus, Inc|Sof foyda CLYM|Sof daromad zurabio.com ZURA|Sof foyda ATYR (aTyr Pharma)|Adagene Inc (ADAG) - Kompaniyaning sof daromadi|IMA: Sof daromad|STTK - Sof foyda|EQ (equilliumbio.com) - Sof daromad|CNTB: Soliqlar to‘langandan keyingi foyda|IMUX (Immunic Therapeutics) - Sof foyda|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|Sof daromad X4 Pharmaceuticals, Inc XFOR|Sof foyda ACET (Adicet Bio, Inc.)|Sof foyda Celularity Inc CELU|INMB - Kompaniyaning sof foydasi|BRNS: Kompaniyaning sof foydasi|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|SABS - Sof moliyaviy natija|Sof daromad AKTX|Kompaniya foydasi ENLV (Enlivex Therapeutics, Ltd.)|Sof daromad QTTB (Q32 Bio Inc.)|Soliqlar to‘langandan keyingi foyda GOVX|Kompaniyaning sof foydasi Edesa EDSA|iBio Corporation - Kompaniyaning sof foydasi|Carisma Tx - Sof foyda|BOLT: Kompaniyaning sof foydasi|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi